Found 4 matching trials
Ibodutant for Relief of Irritable Bowel Syndrome (IRIS)
PHASE2The purpose of the study is to evaluate the benefit of treatment with oral ...
Location
Center for Clinical and Basic Research (CCBR)
12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
PHASE3Irritable Bowel Syndrome with diarrhoea (IBS-D) is a functional gastrointes...
Location
Multiple Locations
12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
PHASE3Irritable Bowel Syndrome with diarrhoea (IBS-D) is a functional gastrointes...
Location
Multiple Locations
52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
PHASE3Irritable Bowel Syndrome with diarrhoea (IBS-D) is a functional gastrointes...
Location
Multiple Locations